Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial | American Diabetes Association

Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial

Speaker: Ofri Mosenzon
Session: New Insights in Diabetic Kidney Disease—Clinical and Experimental Studies (With State-of-the-Art Lecture and ADA Presidents' Select Abstract Presentation)
Congress: 79th Scientific Sessions